Clinical Trial Update: A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine [Phase 3]

View source ↗

Summary

A Phase III trial is evaluating the efficacy, immunogenicity, and safety of an HPV vaccine for human papillomavirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Beijing Health Guard Biotechnology, Inc | Conditions: Human Papillomavirus Infection | Phase 3 | Status: UNKNOWN